Human IGFBP-6(Insulin-like Growth Factor Binding Protein 6) ELISA Kit

The Human IGFBP-6 (Insulin-like Growth Factor Binding Protein 6) ELISA Kit is a highly sensitive and specific assay designed to measure the concentration of IGFBP-6 in human serum, plasma, and other biological fluids. This kit is based on the sandwich enzyme-linked immunosorbent assay (ELISA) principle, which utilizes two specific antibodies that recognize different epitopes of the IGFBP-6 molecule. The assay is easy to perform, with a total assay time of approximately 3 hours, and requires only a small sample volume.

The Human IGFBP-6 ELISA Kit is intended for research use only and is not for diagnostic or therapeutic purposes. IGFBP-6 is a member of the insulin-like growth factor binding protein family, which plays a critical role in regulating the bioavailability and activity of insulin-like growth factors (IGFs). IGFBP-6 binds to IGFs with high affinity and modulates their biological activity by regulating their distribution and clearance in the circulation. Dysregulation of IGFBP-6 expression has been implicated in various diseases, including cancer, diabetes, and cardiovascular disease.

The Human IGFBP-6 ELISA Kit provides a reliable and accurate method for quantifying IGFBP-6 levels in human samples, which can be used to investigate the role of IGFBP-6 in disease pathogenesis and to monitor the efficacy of therapeutic interventions. The kit includes all necessary reagents and controls, and the results can be easily analyzed using a microplate reader. The assay has a wide dynamic range and high sensitivity, with a detection limit of 0.1 ng/mL. Overall, the Human IGFBP-6 ELISA Kit is a valuable tool for researchers studying the biology and pathology of IGFBP-6 and its interactions with IGFs.